Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431 Meeting Abstract


Authors: Hensley, M. L.; Kravetz, S. J.; Jia, X.; Tew, W. P.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C.; Zarwan, C.; Berlin, S. T.
Abstract Title: Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880301623
DOI: 10.1200/jco.2011.29.15_suppl.5090
PROVIDER: wos
Notes: Meeting Abstract: 5090 -- Source: Wos
Altmetric Score
MSK Authors
  1. Xiaoyu Jia
    44 Jia
  2. Paul J Sabbatini
    201 Sabbatini
  3. Martee L Hensley
    221 Hensley
  4. William P Tew
    122 Tew